Abstract | BACKGROUND: METHODS: RESULTS: We report that two ETRB-specific antagonists, A-192621 and BQ788, reduce the number of viable cells in two glioma cell lines in a dose- and time-dependent manner. We describe similar results for two melanoma cell lines. The more potent of the two antagonists, A-192621, decreases the mean number of cell divisions at least in part by inducing a G2/M arrest and apoptosis. Microarray analysis of the effects of A-192621 treatment reveals up-regulation of several DNA damage-inducible genes. These results were confirmed by real-time RT-PCR. Importantly, reducing expression of ETRB with siRNAs does not abrogate the effects of either A-192621 or BQ788 in glioma or melanoma cells. Furthermore, BQ123, an endothelin receptor type A (ETRA)-specific antagonist, has no effect on cell viability in any of these cell lines, indicating that the ETRB-independent effects on cell viability exhibited by A-192621 and BQ788 are not a result of ETRA inhibition. CONCLUSION: While ETRB antagonists reduce the viability of glioma cells in vitro, it appears unlikely that this effect is mediated by ETRB inhibition or cross-reaction with ETRA. Instead, we present evidence that A-192621 affects glioma and melanoma viability by activating stress/DNA damage response pathways, which leads to cell cycle arrest and apoptosis. This is the first evidence linking ETRB antagonist treatment to enhanced expression of DNA damage-inducible genes.
|
Authors | Jennifer P Montgomery, Paul H Patterson |
Journal | BMC cancer
(BMC Cancer)
Vol. 8
Pg. 354
(Nov 28 2008)
ISSN: 1471-2407 [Electronic] England |
PMID | 19040731
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- A 192621
- Endothelin B Receptor Antagonists
- Isoquinolines
- Pyrroles
- Pyrrolidines
- RNA, Small Interfering
- Receptor, Endothelin A
- Receptor, Endothelin B
- WM5 compound
- Ciprofloxacin
|
Topics |
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Ciprofloxacin
(analogs & derivatives, pharmacology)
- DNA Damage
(drug effects, genetics)
- Endothelin B Receptor Antagonists
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Glioma
(genetics, metabolism, pathology)
- Humans
- Isoquinolines
- Melanoma
(genetics, metabolism, pathology)
- Oligonucleotide Array Sequence Analysis
- Pyrroles
- Pyrrolidines
(pharmacology)
- RNA, Small Interfering
- Receptor, Endothelin A
(metabolism)
- Receptor, Endothelin B
(genetics, metabolism)
|